Dynamic Wealth Strategies’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$348K Hold
2,201
– – 0.19% 55
2026
Q1
$281K Hold
2,201
– – 0.16% 64
2025
Q4
$268K Buy
2,201
+80
+4% +$9.17K 0.16% 67
2025
Q3
$213K Hold
2,121
– – 0.14% 67
2025
Q2
$176K Buy
2,121
+219
+12% +$17.5K 0.13% 71
2025
Q1
$154K Buy
+1,902
New +$170K 0.13% 75
2024
Q4
– Sell
-1,902
Closed -$188K – 225
2024
Q3
$188K Buy
1,902
+150
+9% +$14.7K 0.15% 70
2024
Q2
$162K Buy
1,752
+363
+26% +$32.5K 0.14% 77
2024
Q1
$132K Buy
1,389
+211
+18% +$19.6K 0.11% 88
2023
Q4
$105K Buy
+1,178
New +$87.5K 0.1% 93

Other funds holding XBI

Dynamic Wealth Strategies's XBI Position: Q2 2026 in Review

Dynamic Wealth Strategies held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q2 2026 at 2,201 shares worth $348K. The position accounts for 0.19% of the portfolio, ranked #55.

Dynamic Wealth Strategies first reported a position in XBI in Q4 2023 and has held it in 10 quarters since. 936 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • Dynamic Wealth Strategies held 2,201 shares of State Street SPDR S&P Biotech ETF worth $348K as of Q2 2026.
  • Dynamic Wealth Strategies left its State Street SPDR S&P Biotech ETF share count unchanged in Q2 2026.
  • State Street SPDR S&P Biotech ETF made up 0.19% of Dynamic Wealth Strategies's portfolio in Q2 2026, its #55 holding.
  • Dynamic Wealth Strategies first reported a position in State Street SPDR S&P Biotech ETF in Q4 2023 and has held it in 10 quarters since.
  • 936 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Dynamic Wealth Strategies's 13F filing for Q2 2026, filed 23 Jul 2026.